605507 國邦醫藥
按盤價 
23.500 +0.250 (+1.075%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 5.658 | 10.099 | 8.397 | 13.642 | 14.677 |
| 總資產報酬率 ROA (%) | 4.220 | 7.394 | 6.312 | 11.125 | 10.844 |
| 投入資產回報率 ROIC (%) | 4.512 | 7.962 | 6.816 | 11.966 | 11.907 | 邊際利潤分析 |
| 銷售毛利率 (%) | 26.854 | 25.000 | 23.410 | 27.549 | 30.136 |
| 營業利潤率 (%) | 17.252 | 15.194 | 13.128 | 18.404 | 17.951 |
| 息稅前利潤/營業總收入 (%) | 17.203 | 14.568 | 12.176 | 16.914 | 18.530 |
| 淨利潤/營業總收入 (%) | 15.002 | 13.251 | 11.403 | 16.092 | 15.675 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 97.059 | 99.521 | 99.567 | 101.981 | 104.112 |
| 價值變動淨收益/利潤總額(%) | 2.475 | 3.080 | 3.378 | 2.327 | 1.306 |
| 營業外收支淨額/利潤總額(%) | -0.151 | -0.799 | -0.661 | -1.665 | -0.247 | 償債能力分析 |
| 流動比率 (X) | 2.711 | 2.297 | 2.222 | 2.754 | 3.959 |
| 速動比率 (X) | 2.039 | 1.764 | 1.663 | 1.998 | 2.824 |
| 資產負債率 (%) | 25.413 | 25.309 | 28.224 | 20.884 | 15.538 |
| 帶息債務/全部投入資本 (%) | 20.029 | 19.932 | 21.962 | 14.692 | 8.799 |
| 股東權益/帶息債務 (%) | 397.738 | 400.511 | 354.226 | 578.533 | 1,034.220 |
| 股東權益/負債合計 (%) | 293.332 | 294.950 | 254.135 | 378.870 | 543.618 |
| 利息保障倍數 (X) | -731.320 | -28.781 | -14.074 | -14.227 | 29.758 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 49.334 | 39.299 | 40.360 | 34.998 | 33.151 |
| 存貨周轉天數 (天) | 115.771 | 111.304 | 122.036 | 118.058 | 131.463 |
| 備註： | 即時報價更新時間為 01/08/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
